ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
8,000
Total Value
$1,284,979.87
P&L
+inf% (+$1,248,680.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSO & EVP, Head of Research | Common Stock | โ | Feb 12, 2026 | Grant/Award | 4,000 | $0.00 | $0.00 | 25,264 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Feb 13, 2026 | Sale | 1,959 | $310.08 | $607,448.29 | 23,305 | Direct | โ | View Details | |
CSO & EVP, Head of Research | Common Stock | โ | Feb 17, 2026 | Sale | 2,041 | $331.96 | $677,531.58 | 21,264 | Direct | โ | View Details |